Skip to content
Saturday 15 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Friday 23 July 2021 1:19 pm  |  Updated:  Friday 23 July 2021 1:24 pm

Global pharma and data firms have had access to NHS patient data for years, analysis finds

By: Millie Turner

Add as a preferred source on Google

More than 40 pharmaceutical, consultancy and data companies worldwide have access to UK hospital data and medical records, according to new analysis.

The detailed medical records – many from the NHS – date back years, the Financial Times first reported.

Some companies with access to the records are co-founded by the Sackler family, who have built a pharmaceutical dynasty which critics have claimed to have helped fuel the US opioid crisis.

The 43 different commercial organisations include McKinsey & Company, KPMG, Novavax, AstraZeneca, and marketing firm Experian, the analysis discovered.

At least 100 different NHS datasets have been shared with businesses – which include extensive hospital episode statistics, hospitalised patients databases, diagnoses, treatments and outpatient appointments.

There are also smaller datasets about emergency care, mental health, mortality, cancer waiting time, sexual health and childbirth services.

The NHS has been mulling the decision to pool some 55m GP-patient medical records into a single database to be shared with third-party companies for some time.

Concerns about potential conflicts of interest and lack of transparency about what happens with the data after it has been shared have been voiced sporadically over the last five years.

Most of the third-party data recipients are public bodies, such as Transport for London, which are used for planning and research purposes.

However, commercial organisations like KPMG make up some 13 per cent of all data recipients – with figures excluding companies like data analytics group Palantir which was granted emergency access last year for pandemic-related work.

While all data has identifying information like NHS numbers and names are removed, any organisation can apply for access to NHS patient data, following a rigorous safety check.

Patients are often unaware of the NHS’s data-sharing practices, critics argue, as it is difficult to prevent data from entering the outside world even if they do not consent.

Read more

Clinigen Appoints Greg Skalicky as Chief Executive Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • International
  • KPMG
  • McKinsey
  • NHS

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • Revolut chatbot goes rogue by charging users to cancel subscription

  • It’s not just Jason Arday, most of sociology is a scam

More from Morning Wire

  • Clinigen Appoints Greg Skalicky as Chief Executive Officer

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • InterSystems Recognized as a Leader in the Gartner® Magic Quadrant™ for Enterprise Electronic Health Records

    Business Wire
  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
  • The Octus MCP Connector Puts the Most Expansive, Accurate and Verified Credit Intelligence and Data Directly Inside Claude, ChatGPT and Other LLMs

    Business Wire
  • London-listed healthcare services firm hit by cyberattack

    Markets
    Assura has been the subject of a ferocious bidding war for nearly six months
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook